Active Supportive Care and Symptom Management Grants

PI Name Organization - Company Titlesort descending Fiscal Year Topic
Salvemini, Daniela Saint Louis University A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity 2019 Neuropathy
Staff, Nathan P Mayo Clinic Rochester Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology 2019 Neuropathy
Levine, Jon David University Of California, San Francisco Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress 2019 Neuropathy
Accordino, Melissa Columbia University Health Sciences Cryotherapy and Compression Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy in Breast Cancer Patients 2020 Neuropathy
Smith, Ellen Mary Lavoie University Of Michigan At Ann Arbor Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to Phase III Study 2019 Neuropathy
Visovsky, Constance G. University Of South Florida Home-Based Physical Activity Intervention for Taxane-Induced CIPN 2019 Neuropathy
Hammond, Donna L University Of Iowa Phase II Trial of Nicotinamide Riboside for Relief of Taxane-Induced Sensory Neuropathy 2019 Neuropathy
Lustberg, Maryam B Ohio State University Prevention of paclitaxel-induced peripheral neuropathy with nilotinib 2019 Neuropathy
Dougherty, Patrick M University Of Tx Md Anderson Can Ctr The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN 2019 Neuropathy
Gewandter, Jennifer University Of Rochester Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial 2020 Neuropathy, Pain